COCIR Concept on Medical Software

COCIRCOCIR issued an easy-to-use tool to help determine whether software is a medical device or not. Since the revision of the European Medical Device Directive, in force as of 21 March 2010, the definition for medical devices also includes software used for diagnostic and therapeutic purposes. In December 2009, the European Commission decided to develop a European guidance document to clarify which standalone software is a medical device in its own right.

However, European Member States still interpret current regulation inconsistently, which results in unfair competition and different levels of regulatory control affecting patients, users and COCIR's industry members.

The COCIR decision tree together with the explanatory text and examples may help to solve this situation. COCIR has designed this simple tool to determine whether software is to be considered as a medical device in the European regulatory framework. The COCIR decision tree has been developed based on discussions with various stakeholders. It is offered to the European Commission for inclusion in the future European guidance document on Qualification and Classification of Medical Software.

Koen Cobbaert, COCIR Medical Software Task Force Chair stated "With the COCIR decision tree, you can easily find out whether a software application is considered as a medical device and thus must be CE-marked. We are anxiously awaiting European guidance as we see different approaches among regulators."

Nicole Denjoy, COCIR Secretary General, who presented the COCIR tool to the Steering Committee of the Global Harmonisation Task Force (GHTF) in November and said "This decision tree could be a step forward to global convergence of regulation of medical software."

COCIR is freely sharing this concept and is seeking international acceptance. Comments and suggestions on the COCIR decision tree are welcome and can be sent to Olivier Deneve at This email address is being protected from spambots. You need JavaScript enabled to view it..

About COCIR
COCIR is the voice of the European Radiological, Electromedical and Healthcare IT Industry. COCIR is a non-profit trade association, founded in 1959, representing the medical technology industry in Europe. COCIR's members play a driving role in developing the future of healthcare in Europe and worldwide. COCIR moved to Brussels in January 2006, establishing a permanent office in Brussels to better represent industry in its relations with the European institutions. In February 2007, COCIR opened a China Desk in Beijing to strengthen its presence and support for its members in China.

www.cocir.org

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...